Background
Depression and HIV are common comorbid and their symptoms are inter-related. Depression remains disproportionately more prevalent among women who live in low-income countries and HIV circumstances, it is vastly ignored or not identified. Thus, little is known about the experience of depression by women living with HIV. The purpose of this study is to explore the experience of depression among women living with HIV.
Method:
A qualitative study was carried out and this research is a part of the larger mixed-method study. A face-to-face interview was conducted among women who attend Antiretroviral Therapy (ART) and who were eligible after depression screening. An interview guide was used for the data collection and the data was analyzed with the application of N-Vivo (version 11.0). Hence, a total of twenty-one women were recruited in this study.
Results
Women described their experience as stressful life events, lack of participation of social activities, concern over community acceptance, negative self-perception, feelings of hopelessness, including dealing with emotional suffering. However, this finding has revealed, in the course of the multifaceted nature of HIV and depression comorbidity, women’s experience was not constant instead it remained dynamic determined by the different psychosocial and clinical dimensions of the illnesses.
Conclusion
This study has elaborated that HIV positive women’s experience with depression was merely related to their psychosocial aspects, internalized personal attributes, disease traits regarding their life with comorbid diseases; HIV, and depression. Hence, future interventions should focus on the integration of mental health services in the HIV clinical setup.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.